Skip to main content
. 2022 Sep 16;11(18):5440. doi: 10.3390/jcm11185440
ERT Enzyme replacement therapy
FD Fabry disease
CMR Cardiac magnetic resonance
LV Left ventricular
FDCM Fabry Disease Cardiomyopathy
GB-3 Globotriaosylceramide
MWT Maximal wall thickness
M6Pr Mannose-6-phosphate receptors